The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications
Tóm tắt
Từ khóa
Tài liệu tham khảo
Popkin BM . Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr 2010; 91: 284S–288S.
Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. J Clin Endocrinol Metab 2011; 96: 168–175.
Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF . Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26: 573–580.
Yach D, Stuckler D, Brownell KD . Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006; 12: 62–66.
Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK . Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008; 16: 2323–2330.
Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine: Washington, DC, 2010.
Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2010; 128: 1414–1424.
Artaza JN, Mehrotra R, Norris KC . Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515–1522.
Osei K . 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Metab 2010; 95: 4220–4222.
Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888–894.
Kamei Y, Kawada T, Kazuki R, Ono T, Kato S, Sugimoto E . Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 1993; 193: 948–955.
Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D et al. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 1999; 10: 2158–2164.
Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK et al. 1alpha,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008; 112: 122–126.
Alemzadeh R, Kichler J, Babar G, Calhoun M . Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008; 57: 183–191.
Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S et al. Prevalence of vitamin D depletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 98–103.
Ernst B, Thurnheer M, Schmid SM, Schultes B . Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66–73.
Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E . Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 1033–1037.
Jin J, Stellato TA, Hallowell PT, Schuster M, Graf K, Wilhelm S . Utilization of preoperative patient factors to predict postoperative vitamin D deficiency for patients undergoing gastric bypass. J Gastrointest Surg 2009; 13: 1052–1057.
Mahlay NF, Verka LG, Thomsen K, Merugu S, Salomone M . Vitamin D status before Roux-en-Y and efficacy of prophylactic and therapeutic doses of vitamin D in patients after Roux-en-Y gastric bypass surgery. Obes Surg 2009; 19: 590–594.
Stein EM, Strain G, Sinha N, Ortiz D, Pomp A, Dakin G et al. Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. Clin Endocrinol (Oxf) 2009; 71: 176–183.
Signori C, Zalesin KC, Franklin B, Miller WL, McCullough PA . Effect of gastric bypass on vitamin D and secondary hyperparathyroidism. Obes Surg 2010; 20: 949–952.
Vilarrasa N, Maravall J, Estepa A, Sanchez R, Masdevall C, Navarro MA et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30: 653–658.
Brock K, Huang WY, Fraser DR, Ke L, Tseng M, Stolzenberg-Solomon R et al. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 2010; 121: 462–466.
Aasheim E, Hofs D, Hjelmesaeth J, Birkeland K, Bhmer T . Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87: 362–369.
Chai W, Conroy S, Maskarinec G, Franke A, Pagano I, Cooney R . Associations between obesity and serum lipid-soluble micronutrients among premenopausal women. Nutr Res 2010; 30: 227–232.
Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251–4257.
Flores L, Osaba MJ, Andreu A, Moize V, Rodriguez L, Vidal J . Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism. Obes Surg 2010; 20: 738–743.
Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R . Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)—a prospective study. Obesity Surg 2010; 20: 447–453.
Goldner WS, Stoner JA, Thompson J, Taylor K, Larson L, Erickson J et al. Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg 2008; 18: 145–150.
Granado-Lorencio F, Simal-Anton A, Salazar-Mosteiro J, Herrero-Barbudo C, Donoso-Navarro E, Blanco-Navarro I et al. Time-course changes in bone turnover markers and fat-soluble vitamins after obesity surgery. Obes Surg 2010; 20: 1524–1529.
Khandalavala BN, Hibma PP, Fang X . Prevalence and persistence of vitamin D deficiency in biliopancreatic diversion patients: a retrospective study. Obes Surg 2010; 20: 881–884.
Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J . Vitamin D status of morbidly obese bariatric surgery patients. J Surg Res 2010; 164: 198–202.
Compher CW, Badellino KO, Boullata JI . Vitamin D and the bariatric surgical patient: a review. Obes Surg 2008; 18: 220–224.
Bischof MG, Heinze G, Vierhapper H . Vitamin D status and its relation to age and body mass index. Horm Res 2006; 66: 211–215.
McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD . Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7: 4.
Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A et al. 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 2010; 18: 1906–1910.
Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196–1199.
Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G . Cross-sectional and longitudinal relation between serum 25-hydroxyvitamin D and body mass index: the Tromsø study. Eur J Nutr 2010; 49: 401–407.
Vilarrasa N, Vendrell J, Maravall J, Elo I, Solano E, San Jos P et al. Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 2010; 38: 235–242.
Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, Sahin H et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2009; 280: 559–563.
Kremer R, Campbell PP, Reinhardt T, Gilsanz V . Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 2009; 94: 67–73.
Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, Zonderman AB . Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 2010; 95: 3814–3827.
Valina-Toth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, Flack JM . Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 2010; 72: 595–603.
Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, Bryer-Ash M et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 2009; 94: 3306–3313.
Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242–248.
Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 2010; 95: 1076–1083.
Yanoff LB, Parikh SJ, Spitalnik A, Denkinger B, Sebring NG, Slaughter P et al. The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) 2006; 64: 523–529.
Winters SJ, Chennubhatla R, Wang C, Miller JJ . Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 2009; 58: 438–442.
Norman AW . From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008; 88: 491S–499S.
Rueda S, Fernandez-Fernandez C, Romero F, Martinez de Osaba J, Vidal J . Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008; 18: 151–154.
Clements RH, Yellumahanthi K, Wesley M, Ballem N, Bland KI . Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass. Am Surg 2008; 74: 469–474.
Lagunova Z, Porojnicu AC, Vieth R, Lindberg FA, Hexeberg S, Moan J . Serum 25-hydroxyvitamin D is a predictor of serum 1,25-dihydroxyvitamin D in overweight and obese patients. J Nutr 2011; 141: 112–117.
Frost M, Abrahamsen B, Nielsen TL, Hagen C, Andersen M, Brixen K . Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism. Clin Endocrinol (Oxf) 2010; 73: 573–580.
Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R . Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008; 47: 87–91.
Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690–693.
Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J et al. Vitamin D(3) in fat tissue. Endocrine 2008; 33: 90–94.
Lin E, Armstrong-Moore D, Liang Z, Sweeney JF, Torres WE, Ziegler TR et al. Contribution of adipose tissue to plasma 25-hydroxyvitamin D concentrations during weight loss following gastric bypass surgery. Obesity (Silver Spring) 2010; 19: 588–594.
Aasheim ET, Bjorkman S, Sovik TT, Engstrom M, Hanvold SE, Mala T et al. Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 2009; 90: 15–22.
Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P et al. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab 2010; 95: 4251–4257.
Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517–524.
Kull M, Kallikorm R, Lember M . Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 2009; 39: 256–258.
Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S . Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 2007; 103: 679–681.
Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C . Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007; 77: 47–57.
Compher C, Badellino KO . Obesity and inflammation: lessons from bariatric surgery. J Parenter Enteral Nutr 2008; 32: 645–647.
Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S . Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010–1013.
Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009; 94: 4023–4030.
Oh J, Weng S, Felton SK, Bhandare S, Riek A, Butler B et al. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009; 120: 687–698.
Jorde R, Sneve M, Torjesen PA, Figenschau Y, Goransson LG, Omdal R . No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine 2010; 50: 175–180.
Rayalam S, Della-Fera MA, Ambati S, Yang JY, Park HJ, Baile CA . Enhanced effects of 1,25(OH)(2)D(3) plus genistein on adipogenesis and apoptosis in 3T3-L1 adipocytes. Obesity (Silver Spring) 2008; 16: 539–546.
Kong J, Li YC . Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 2006; 290: E916–E924.
Vieth R . Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of ‘free’ 1,25-dihydroxyvitamin D. Clin Chem 1994; 40: 435–441.
Gonzales AM, Orlando RA . Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) 2007; 4: 22.
Dani C, Amri EZ, Bertrand B, Enerback S, Bjursell G, Grimaldi P et al. Expression and regulation of pOb24 and lipoprotein lipase genes during adipose conversion. J Cell Biochem 1990; 43: 103–110.
Tontonoz P, Kim JB, Graves RA, Spiegelman BM . ADD1: a novel helix–loop–helix transcription factor associated with adipocyte determination and differentiation. Mol Cell Biol 1993; 13: 4753–4759.
Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22: 2941–2952.
Christy RJ, Yang VW, Ntambi JM, Geiman DE, Landschulz WH, Friedman AD et al. Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes. Genes Dev 1989; 3: 1323–1335.
Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM . mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224–1234.
Tontonoz P, Hu E, Spiegelman BM . Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79: 1147–1156.
Freytag SO, Geddes TJ . Reciprocal regulation of adipogenesis by Myc and C/EBP alpha. Science 1992; 256: 379–382.
Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 2009; 296: E820–E828.
Boon N, Hul GB, Sicard A, Kole E, Van Den Berg ER, Viguerie N et al. The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 2006; 14: 1739–1746.
Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance—a prospective randomized double-blind study. Acta Med Scand 1987; 222: 361–367.
Ortega RM, Lopez-Sobaler AM, Aparicio A, Bermejo LM, Rodriguez-Rodriguez E, Perea JM et al. Vitamin D status modification by two slightly hypocaloric diets in young overweight/obese women. Int J Vitam Nutr Res 2009; 79: 71–78.
Teegarden D, White KM, Lyle RM, Zemel MB, Van Loan MD, Matkovic V et al. Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 2008; 16: 1566–1572.
Chan She Ping-Delfos W, Soares M . Diet induced thermogenesis, fat oxidation and food intake following sequential meals: Influence of calcium and vitamin D. Clinical Nutrition 2011; 30: 376–383.
Sneve M, Figenschau Y, Jorde R . Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008; 159: 675–684.
Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321–1327.
McCarty MF, Thomas CA . PTH excess may promote weight gain by impeding catecholamine-induced lipolysis—implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses 2003; 61: 535–542.
Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC . Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132–1138.
Holecki M, Zahorska-Markiewicz B, Wiecek A, Mizia-Stec K, Nieszporek T, Zak-Golab A . Influence of calcium and vitamin D supplementation on weight and fat loss in obese women. Obes Facts 2008; 1: 274–279.
Shahar D, Schwarzfuchs D, Fraser D, Vardi H, Thiery J, Fiedler G et al. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010; 92: 1017–1022.
Carlin AM, Rao DS, Yager KM, Genaw JA, Parikh NJ, Szymanski W . Effect of gastric bypass surgery on vitamin D nutritional status. Surg Obes Relat Dis 2006; 2: 638–642.
Gasteyger C, Suter M, Gaillard RC, Giusti V . Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128–1133.
Madan AK, Orth WS, Tichansky DS, Ternovits CA . Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg 2006; 16: 603–606.
Pajecki D, Dalcanalle L, Souza de Oliveira CP, Zilberstein B, Halpern A, Garrido Jr AB et al. Follow-up of Roux-en-Y gastric bypass patients at 5 or more years postoperatively. Obes Surg 2007; 17: 601–607.
Carlin AM, Yager KM, Rao DS . Vitamin D depletion impairs hypertension resolution after Roux-en-Y gastric bypass. Am J Surg 2008; 195: 349–352.
Norman AW, Deluca HF . The preparation of H3-vitamins D2 and D3—their localization in the rat. Biochemistry 1963; 2: 1160–1168.
Schachter D, Finkelstein JD, Kowarski S . Metabolism of vitamin D. I. Preparation of radioactive vitamin D and its intestinal absorption in the rat. J Clin Invest 1964; 43: 787–796.
Goldner WS, Stoner JA, Lyden E, Thompson J, Taylor K, Larson L et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 2009; 19: 173–179.
Williams SE . Bariatric surgery and skeletal health. www.osteoporosissymptoms.org/cmexam/Issue19BariatricSurgery/bariatric.htm 2010.